Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ATAI Life Sciences N.V. - Common Shares
(NQ:
ATAI
)
2.710
+0.520 (+23.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ATAI Life Sciences N.V. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Nasdaq Dips 150 Points; US ISM Manufacturing PMI Rises In June
Today 12:51 EDT
Via
Benzinga
Which stocks are experiencing notable movement on Tuesday?
Today 12:30 EDT
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday
Today 10:38 EDT
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Today 10:30 EDT
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
DOD to Invest $9.8m into Psychedelic Studies Targeting Active-Duty Soldiers
March 19, 2025
Via
Investor Brand Network
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
Today 9:50 EDT
From
FN Media Group LLC
Via
GlobeNewswire
Atai Life Sciences And Merger Partner Set Up Psychedelic Depression Therapy With Encouraging Late-Stage Data
Today 9:28 EDT
Atai and Beckley report that a single dose of BPL-003 reduced depression symptoms significantly and safely in treatment-resistant patients.
Via
Benzinga
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
Today 9:45 EDT
EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Get insights into the top gainers and losers of Tuesday's pre-market session.
Today 8:30 EDT
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Via
Chartmill
atai Life Sciences Announces $50 Million Private Placement Financing
Today 6:05 EDT
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1
From
atai Life Sciences
Via
GlobeNewswire
5 Biotech Stocks with Highly Anticipated Pending Results
June 26, 2025
Via
Stocktwits
Topics
Intellectual Property
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders
June 15, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
Today 6:00 EDT
From
atai Life Sciences
Via
GlobeNewswire
CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 04, 2025
Via
Benzinga
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders
June 03, 2025
From
Halper Sadeh LLC
Via
Business Wire
Atai Life Sciences Stock Rockets On Merger Plans With Beckley Psytech; Retail Traders Eye Every Dip
June 02, 2025
The merger focuses on creating a combined company focused on psychedelic mental health therapies.
Via
Stocktwits
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
June 02, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in Upcoming Investor Conferences
May 29, 2025
From
atai Life Sciences
Via
GlobeNewswire
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
Via
Benzinga
Topics
Government
Atai Life Sciences Stock Soars To 3-Month High As Depression Study Yields Promising Results: Retail Bulls Cheer
May 21, 2025
Atai Life Sciences shares surged 11.4% after Beckley Psytech reported encouraging Phase 2a results of its depression treatment
Via
Stocktwits
atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression
May 20, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates
May 14, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder
May 13, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
March 17, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression
March 11, 2025
From
atai Life Sciences
Via
GlobeNewswire
Study Finds That Bad Psychedelic Trips Double Some Individuals’ Fatality Risk
March 05, 2025
Via
Investor Brand Network
atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression
March 05, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
February 24, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
February 20, 2025
From
atai Life Sciences
Via
GlobeNewswire
Veterans Turn to One Another for Help Using Psychedelics to Combat Mental Health Challenges
February 19, 2025
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.